20381266

Source:http://linkedlifedata.com/resource/pubmed/id/20381266

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006826, umls-concept:C0035020, umls-concept:C0205147, umls-concept:C1512814
pubmed:issue	2
pubmed:dateCreated	2011-1-3
pubmed:abstractText	To evaluate the regional relapse rate in the elective neck using intensity-modulated radiotherapy (IMRT) for head-and-neck cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	1879-355X
pubmed:author	pubmed-author:BonteKatrienK, pubmed-author:BoterbergTomT, pubmed-author:De GersemWernerW, pubmed-author:De NeveWilfriedW, pubmed-author:DuprezFrédericF, pubmed-author:MadaniIndiraI
pubmed:copyrightInfo	Copyright Â© 2011 Elsevier Inc. All rights reserved.
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	79
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	450-8
pubmed:meshHeading	pubmed-meshheading:20381266-Adult, pubmed-meshheading:20381266-Aged, pubmed-meshheading:20381266-Aged, 80 and over, pubmed-meshheading:20381266-Antineoplastic Agents, pubmed-meshheading:20381266-Carcinoma, Squamous Cell, pubmed-meshheading:20381266-Combined Modality Therapy, pubmed-meshheading:20381266-Female, pubmed-meshheading:20381266-Follow-Up Studies, pubmed-meshheading:20381266-Head and Neck Neoplasms, pubmed-meshheading:20381266-Humans, pubmed-meshheading:20381266-Lymph Node Excision, pubmed-meshheading:20381266-Lymphatic Metastasis, pubmed-meshheading:20381266-Male, pubmed-meshheading:20381266-Middle Aged, pubmed-meshheading:20381266-Radiotherapy, Intensity-Modulated, pubmed-meshheading:20381266-Radiotherapy Dosage, pubmed-meshheading:20381266-Retrospective Studies
pubmed:year	2011
pubmed:articleTitle	Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer.
pubmed:affiliation	Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium. frederic.duprez@ugent.be
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't